Pathophysiology of hypertension in pre-eclampsia: a lesson in integrative physiology
about
Calcium supplementation commencing before or early in pregnancy, or food fortification with calcium, for preventing hypertensive disorders of pregnancyPlacental origins of adverse pregnancy outcomes: potential molecular targets: an Executive Workshop Summary of the Eunice Kennedy Shriver National Institute of Child Health and Human DevelopmentInhibition of ENaC by endothelin-1Neutrophil Depletion Attenuates Placental Ischemia-Induced Hypertension in the RatAltered matrix metalloproteinase-2 and -9 expression/activity links placental ischemia and anti-angiogenic sFlt-1 to uteroplacental and vascular remodeling and collagen deposition in hypertensive pregnancy.The Gene Variants of Maternal/Fetal Renin-Angiotensin System in Preeclampsia: A Hybrid Case-Parent/Mother-Control Study.Reassessing the impact of smoking on preeclampsia/eclampsia: are there age and racial differences?Regulation of calcitriol biosynthesis and activity: focus on gestational vitamin D deficiency and adverse pregnancy outcomes.Reduced uterine perfusion pressure induces hypertension in the pregnant mouse.Chronic hyperleptinemia results in the development of hypertension in pregnant rats.The Dahl salt-sensitive rat is a spontaneous model of superimposed preeclampsia.Maternal characteristics and mid-pregnancy serum biomarkers as risk factors for subtypes of preterm birth.Sildenafil Treatment Ameliorates the Maternal Syndrome of Preeclampsia and Rescues Fetal Growth in the Dahl Salt-Sensitive Rat.Fetal programming and cardiovascular pathology.Mechanisms of Endothelial Dysfunction in Hypertensive Pregnancy and Preeclampsia.The Endothelin Type A Receptor as a Potential Therapeutic Target in Preeclampsia.Selective endothelin inhibition in diabetic nephropathy: is it the icing on the cake?Endothelial dysfunction and vascular disease - a 30th anniversary update.Increased vascular and uteroplacental matrix metalloproteinase-1 and -7 levels and collagen type I deposition in hypertension in pregnancy: role of TNF-α.Deconstructing the smoking-preeclampsia paradox through a counterfactual framework.ACE gene in pregnancy complications: Insights into future vascular risk.Effects of NAMPT polymorphisms and haplotypes on circulating visfatin/NAMPT levels in hypertensive disorders of pregnancy.Maternal and fetal outcome in de novo preeclampsia in comparison to superimposed preeclampsia: a two-year observational study.Poly-N-acryloyl-(l-phenylalanine methyl ester) hollow core nanocapsules facilitate sustained delivery of immunomodulatory drugs and exhibit adjuvant properties.Evaluation of anti-Mullerian hormone in the first trimester as a predictor for hypertensive disorders of pregnancy and other adverse pregnancy outcomes.Calcium supplementation commencing before or early in pregnancy, or food fortification with calcium, for preventing hypertensive disorders of pregnancy.The variations in the IL1RL1 gene and susceptibility to preeclampsia.Matrix Metalloproteinases in Normal Pregnancy and Preeclampsia.Matrix Metalloproteinases, Vascular Remodeling, and Vascular Disease.Continued Investigation Into 17-OHPC: Results From the Preclinical RUPP Rat Model of Preeclampsia.A Maternally Sequestered, Biopolymer‐Stabilized Vascular Endothelial Growth Factor (VEGF) Chimera for Treatment of Preeclampsia.Immune regulation of systemic hypertension, pulmonary arterial hypertension, and preeclampsia: shared disease mechanisms and translational opportunities.Role of angiogenic factors in the pathogenesis and management of pre-eclampsia.ADAMTS 1, 4, 12, and 13 levels in maternal blood, cord blood, and placenta in preeclampsia.Decreased homodimerization and increased TIMP-1 complexation of uteroplacental and uterine arterial matrix metalloproteinase-9 during hypertension-in-pregnancy.Vitamin D supplementation reduces some AT1-AA-induced downstream targets implicated in preeclampsia including hypertension.New Predictive Model at 11+0 to 13+6 Gestational Weeks for Early-Onset Preeclampsia With Fetal Growth Restriction.Sodium hydrosulfide prevents hypertension and increases in vascular endothelial growth factor and soluble fms-like tyrosine kinase-1 in hypertensive pregnant rats.The Endothelin System: A Critical Player in the Pathophysiology of Preeclampsia.Impact of particulate matter on mothers and babies in Antwerp (IPANEMA): a prospective cohort study on the impact of pollutants and particulate matter in pregnancy.
P2860
Q24194579-407FE8E4-EEAD-4720-B2B9-3ABD6D03967DQ26766128-A6C08267-9974-4C85-BA23-C3CF0F3BE95FQ27005957-19B07503-215A-45C1-B4D9-358AC941736CQ27303128-C75DCFBA-B8E7-4F95-8BAB-9ACD63434163Q33665037-A5C3893E-C4B8-48FD-86D8-BE0DF037640EQ33895023-8643648D-03F5-442C-954D-D968B2878756Q34387263-8B9A9F65-521C-40A3-942B-3FD35AE3D224Q34458016-19B5C61B-D130-41F0-A7B3-41561484D628Q34627421-8D45031B-F0D7-417A-B168-49426DDD4AE7Q35622378-2DE96821-9312-44D5-893B-8EDBD0EDD277Q35817935-A4816ECF-1A1B-4CA4-B432-1C5668D55EE3Q36439778-200BA5E4-01EB-427E-B65B-CF32B04859E0Q36576619-86DEBE2C-C7E4-4108-BB5A-7D55D3C07D1FQ36635518-A8DE33EA-5D37-401C-A736-AB43849A5920Q37136212-3DD13C13-DF6A-4FE7-9C08-DE3809118080Q37729072-247481B7-97A8-464B-A132-891D58196388Q38221725-81C7940D-0B12-4410-A7C2-FDEC49F421B4Q38680112-DB7F3206-E4CC-4EA0-829A-022204585ACDQ38720237-31AA1417-69C0-4E5C-8D35-D4965CD249BDQ38895349-335682B1-E90E-4FF4-9AF5-477A6D4806E9Q38903920-97CFE3FC-5D12-458D-97B2-E20AE8ED2D97Q39035294-06123EE9-414C-4956-84D9-6260D40E25E3Q39395309-3DAC9861-869D-43DF-A887-F352448D52AFQ40054092-BB3422D8-210A-403F-9F8A-8EF9828BA7A1Q44317575-02B25562-E705-4EDC-98C4-98110B7CD759Q46302440-BF61860D-7ACD-465A-A6CD-BD4928CF69F0Q46317388-EEC84DFC-EAD8-4D50-9FDB-CAB819E7FF86Q46342648-42D0765E-A5CD-492E-B055-326DBB424DF4Q47223491-F40A0742-5605-4BE6-80F1-F505FA5224FAQ47688833-07A4C6F2-BE0B-4ACB-A247-BB3164629D7EQ49212311-FC5693F0-3978-40D5-B094-FC39620A430DQ49600503-7A2B76D6-E316-419D-B73E-C94753AD256EQ49984490-642ED938-4791-4CA8-91FF-F2E83FFBD741Q50033312-4585B0E4-3C5B-4ABC-9BB9-2F0C6375CAE7Q51000408-11153442-0561-4C77-BF4F-2A5F63F9337AQ51294484-F80688D2-5E2E-4420-9592-42BD56422C09Q51454988-8DB8E3DA-188E-4D37-A097-BFD5FC673173Q51515268-2F15DDDE-3ED3-479E-89F5-1A117550AE9BQ52594781-44F49079-85FE-4FF6-BDA9-A9014A1F0635Q52662461-73A285DF-70FB-43FF-AFF1-6575C1C801A8
P2860
Pathophysiology of hypertension in pre-eclampsia: a lesson in integrative physiology
description
2013 nî lūn-bûn
@nan
2013 թուականի Յուլիսին հրատարակուած գիտական յօդուած
@hyw
2013 թվականի հուլիսին հրատարակված գիտական հոդված
@hy
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
name
Pathophysiology of hypertension in pre-eclampsia: a lesson in integrative physiology
@ast
Pathophysiology of hypertension in pre-eclampsia: a lesson in integrative physiology
@en
Pathophysiology of hypertension in pre-eclampsia: a lesson in integrative physiology
@nl
type
label
Pathophysiology of hypertension in pre-eclampsia: a lesson in integrative physiology
@ast
Pathophysiology of hypertension in pre-eclampsia: a lesson in integrative physiology
@en
Pathophysiology of hypertension in pre-eclampsia: a lesson in integrative physiology
@nl
prefLabel
Pathophysiology of hypertension in pre-eclampsia: a lesson in integrative physiology
@ast
Pathophysiology of hypertension in pre-eclampsia: a lesson in integrative physiology
@en
Pathophysiology of hypertension in pre-eclampsia: a lesson in integrative physiology
@nl
P2093
P2860
P921
P356
P1433
P1476
Pathophysiology of hypertension in pre-eclampsia: a lesson in integrative physiology
@en
P2093
A. C. Palei
E. M. George
F. T. Spradley
J. P. Granger
P2860
P304
P356
10.1111/APHA.12106
P407
P577
2013-07-01T00:00:00Z